Jennings American Legion Hospital Earns ‘Top Performer on Key Quality Measures®’ Recognition from The Joint Commission

November 23, 2015– Jennings American Legion Hospital announced today that it has been recognized as a 2014 Top Performer on Key Quality Measures® by The Joint Commission, the leading accreditor of health care organizations in the United States.

Jennings American Legion Hospital was recognized as part of The Joint Commission’s 2015 annual report “America’s Hospitals: Improving Quality and Safety,” for attaining and sustaining excellence in accountability measure performances. Jennings American Legion Hospital is one of only 1,043 hospitals out of more than 3,300 eligible hospitals in the United States to achieve the 2014 Top Performer distinction.

The Top Performer program recognizes hospitals for improving performance on evidence-based interventions that increase the chances of healthy outcomes for patients with certain conditions. The performance measures included in the recognition program including heart attack, heart failure, pneumonia, surgical care, children’s asthma, inpatient psychiatric services, stroke, venous thromboembolism, perinatal care, immunization, tobacco treatment and substance use.

To be a 2014 Top Performer, hospitals had to meet three performance criteria based on 2014 accountability measure data, including:

• Achieve cumulative performance of 95 percent or above across all reported accountability measures;
• Achieve performance of 95 percent or above on each and every reported accountability measure with at least 30 denominator cases; and
• Have at least one core measure set that had a composite rate of 95 percent or above, and within that measure set, achieve a performance rate of 95 percent or above on all applicable individual accountability measures.

“Delivering the right treatment in the right way at the right time is a cornerstone of high-quality health care. I commend the efforts of Jennings American Legion Hospital for their excellent performance on the use of evidence-based interventions,” said Mark R. Chassin, MD, FACP, MPP, MPH, president and CEO, The Joint Commission.